Sat.Jul 15, 2023 - Fri.Jul 21, 2023

article thumbnail

7 best practices for assessing eCOA technology solutions

pharmaphorum

7 best practices for assessing eCOA technology solutions Mike.

96
article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Community Pharmacy’s Next Mission: Closing Immunization Gaps Among Vulnerable and Underserved Populations

Pharmacy Times

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

article thumbnail

Interventions Tailored to Race, Gender Could Help Decrease Drug Overdose Deaths

Drug Topics

Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.

187
187
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Patients Often Lose in the Battle Between Pharmaceutical Companies and PBMs

Drug Topics

Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.

article thumbnail

How long should immune checkpoint inhibitor therapy be used in non-small cell lung cancer?

Hospital Pharmacy Europe

Immune checkpoint inhibitors have transformed the management of non-small cell lung cancer, but how long should treatment be continued for optimal survival? Rod Tucker takes a closer look at the evidence. It has long been recognised that a hallmark of cancer is immune evasion and that the immune system is held back by inhibitory immune checkpoint receptors and ligands.

More Trending

article thumbnail

Pure Oxygen Treatment May Significantly Improve Motor Learning Processes

Pharmacy Times

Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.

123
123
article thumbnail

Therapeutic Drug Monitoring May Be Future of Inflammatory Bowel Disease Management

Pharmacy Times

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

123
123
article thumbnail

Medicare proposes broadening Alzheimer's brain scan coverage

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) could remove PET scan restrictions to better determine whether patients qualify for new drugs and to shine light on whether a drug is slowing | CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline.

98
article thumbnail

What You Need to Know About the Albuterol Shortage

Drug Topics

The FDA is working quickly to address shortages of the form used in nebulizers.

FDA 187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Three things to know from the latest Patient Experience Survey

PhRMA

Most insured Americans believe insurance should provide affordable access to health care (93%), but only a third (34%) say it does, according to the fourth installment of the Patient Experience Survey (PES). The survey — based on interviews with 5,000 Americans — explores this disconnect, detailing the challenges insured Americans face affording care and how practices by health insurers and middlemen put patient lifelines to access at risk.

Insurance 133
article thumbnail

Atezolizumab, Bevacizumab Combination May Increase Risk of Cardiac Toxicity in Patients with Liver Cancer

Pharmacy Times

Quitting treatment may significantly improve severe hypertension in patients with hepatocellular carcinoma.

123
123
article thumbnail

Amazon’s palm payment method to be available at Whole Foods stores nationwide

Drug Store News

Whole Foods customers who choose to use Amazon One will no longer need their wallet or even a phone to pay.

98
article thumbnail

Monthly Buprenorphine Initiation Rates Remain Flat, Despite Policy Changes

Drug Topics

Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days.

187
187
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Digital transformation in pharma: The importance of digitalisation

pharmaphorum

Digital transformation in pharma: The importance of digitalisation Mike.

98
article thumbnail

Do Pharmaceutical Brand Colors Affect Consumer Buying Decisions?

Pharmacy Times

A company’s choice of color for branding and logo design may impact how consumers feel about the brand and could influence buyer decision-making.

123
123
article thumbnail

Regulators warn hospitals and telehealth companies about privacy risks of Meta, Google tracking tech

Fierce Healthcare

Federal regulators are warning hospital systems and telehealth providers about the data privacy risks of using third-party tracking technologies. | Federal regulators sent letters to 130 hospital systems and telehealth providers warning them about the data privacy and security risks related to the use of online tracking technologies integrated into their websites or mobile apps.

article thumbnail

DSCSA is Coming. Are you Ready?

Drug Topics

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.

187
187
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year.

article thumbnail

Mortality Rate of Individuals With Alzheimer Disease, Dementias Increased During COVID-19 Pandemic

Pharmacy Times

The research narrows the most at-risk populations and how to mitigate the impacts on adults with ADRD.

123
123
article thumbnail

Misdiagnoses cost the U.S. 800,000 deaths and serious disabilities every year, study finds

STAT

Diagnostic errors — that is, overlooking a disease, or diagnosing it erroneously or late — are a known occurrence in health care, and one that can have tragic effects. Yet so far there have been few attempts to quantify misdiagnoses in terms of deaths and permanent disability, and the full scale of their impact has been underestimated by the medical community, according to a 2015 report by the National Academy of Medicine.

98
article thumbnail

Four Simple Steps to Turn a Pharmacy’s Front End Into a Profit Magnet

Drug Topics

Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.

article thumbnail

Determining accurate estimation of true endotoxin concentration

European Pharmaceutical Review

A semi-quantitative limulus amebocyte lysate (LAL) gel clot test with a narrow dilution range can be valuable for relatively accurate estimation of endotoxin in biopharmaceutical products, research shows. The paper published in Vaccine Research demonstrated the compatibility and benefits of LAL gel clot tests in a semi-quantitative manner compared to the LAL chromogenic assay.

article thumbnail

Study Findings Urge Use of Personalized Hearing Aids for Older Individuals

Pharmacy Times

Individuals with age-related hearing loss should not be treated with “standard” hearing aids, but fitted to their personal needs, while avoiding settings that add distortion.

123
123
article thumbnail

After FDA snub, Daiichi's Vanflyta gains US approval and tees up AML clash with Novartis, Astellas

Fierce Pharma

If at first you don’t succeed, try, try again. That’s the lesson Daiichi Sankyo likely took home Friday after scoring a long-awaited U.S. | Some four years after Daiichi Sankyo's quizartinib scored its initial green light in Japan—and suffered a slap-down from drug regulators stateside—the acute myeloid leukemia medicine has won the FDA’s blessing.

FDA 98
article thumbnail

Traveling With Daily Medications? Keep These Tips in Mind

Drug Topics

A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.

187
187
article thumbnail

Boiron’s Arnicare debuts Arthritis Cream

Drug Store News

The topical medicine contains harpagophytum, otherwise known as devil’s claw, to treat symptoms of arthritis.

98
article thumbnail

Search Engines Provide Higher Quality Information on HIV PrEP Compared to Virtual Assistants

Pharmacy Times

For adolescents and young adults affected by HIV, Google yielded higher quality information on pre-exposure prophylaxis more frequently compared to other search engines.

123
123
article thumbnail

STAT+: White House launches permanent pandemic office

STAT

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic. The Office of Pandemic Preparedness and Response Policy is a now-permanent installment in Washington and will first be led by retired Major General Paul Friedrichs, a longtime biosecurity official.

article thumbnail

The Senior Citizen Vote Is Feared With Good Reason

Drug Topics

Despite the increase in drug costs outpacing inflation, Pennsylvania seniors are still paying the same amount for prescriptions that they did in 1990.

186
186
article thumbnail

Sandoz to build Slovenian biosimilar development facility

European Pharmaceutical Review

To support future growth of its biosimilar pipeline, Sandoz is planning to build a Biosimilar Technical Development Center in Slovenia. The company intends to invest approximately $90 million at its site in Ljubljana, Slovenia, to establish a dedicated Sandoz Biopharma Development Center by 2026. With this financial boost, the Ljubljana site is set to become a key location for biosimilar product development at Sandoz. “The new Biosimilar Development Center in Ljubljana will …[help] Sandoz

98
article thumbnail

DIR Fee Reform Will Have Repercussions in 2024, But Pharmacists Can Prepare

Pharmacy Times

Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024.

123
123
article thumbnail

Providers improperly collected $784M from a fund for uninsured COVID patients. Now, the government wants it back

Fierce Healthcare

A pandemic program that distributed funds for uninsured patients’ COVID-19 testing and treatment made nearly $784 million in improper payments to healthcare providers, money the government should b | A recent audit estimated that COVID testing and treatment payments for millions of uninsured patients shouldn't have happened. The government agency responsible for the program says it's now working to claw those funds back from providers.

98